Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01837875 · ClinicalTrials.gov registry record · NA

Intervention to Improve Quality of Life in African American Lupus Patients

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
153
Enrollment target

NCT01837875: Completed NA study, sponsored by Medical University of South Carolina.

NCT01837875 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 153 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01837875, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
153 participants
Enrollment target

Study Summary

The goal of the proposed project is to enhance the Principal Investigator's research ability to conduct behavioral interventions for people with lupus. This includes intervention design, implementation, data collection and data analysis. The Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN) Project is designed to examine whether a uniquely tailored intervention program can improve quality of life, decrease indicators of depression, and reduce perceived and biological indicators of stress in African American lupus patients. This study builds on three decades of work conducted in the field of arthritis self-management but differs in that the intervention mode, the disease (lupus), and the study population (African-Americans) are unstudied or understudied. The IQAN Project will use the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) model as its theoretical framework. This program has three specific aims. The first aim seeks to design a three armed randomized, wait list controlled trial that employs a patient-centered 'a-la-carte' approach that offers subjects a variety of modes of interaction, allowing them to choose as many or few as they wish. The second aim is to assess the intervention, using the RE-AIM model framework. The third aim, to be achieved before the first aim, is to use previously collected data to characterize patient-centric barriers to care in African-American lupus patients, in order to identify trends in patient needs and desires, as well as correlates of non-response and non-compliance that can be used in the development and refinement of the intervention.

Interventions

  • BEHAVIORAL Chronic Disease Self-Management Program (CDSMP)
  • BEHAVIORAL Support group
  • BEHAVIORAL Mail-delivered arthritis kit
  • BEHAVIORAL Listserv

Trial Details

FieldValue
Enrollment Target 153 participants
Start Date 2013-04
Est. Completion 2016-08-31
Phase NA

What the finished NCT01837875 record still lists

NCT01837875 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 4 interventions - of which Chronic Disease Self-Management Program (CDSMP) is the first listed.

NCT01837875 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01837875 about?

NCT01837875 is a clinical study titled "Intervention to Improve Quality of Life in African American Lupus Patients". The goal of the proposed project is to enhance the Principal Investigator's research ability to conduct behavioral interventions for people with lupus. This includes intervention design, implementation, data collection and data analysis. The Intervention to Improve Quality of life for African-Americ...

What is the current status of trial NCT01837875?

This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2013-04. Estimated completion is 2016-08-31.

What interventions are being tested in trial NCT01837875?

The interventions under investigation include: Chronic Disease Self-Management Program (CDSMP) (BEHAVIORAL), Support group (BEHAVIORAL), Mail-delivered arthritis kit (BEHAVIORAL), Listserv (BEHAVIORAL).

Who is sponsoring clinical trial NCT01837875?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01837875's enrollment target sits among peer trials

153 656th of 2000 higher than 1,343 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05283265 · 153 participants · NA

    Neurophysiological Mechanisms of Language Comprehension

  • NCT05554393 · 153 participants · Phase 2

    Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

  • NCT05584501 · 153 participants · NA

    ETE Interventions in the Dental Setting

  • NCT05714839 · 153 participants · Phase 1

    A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01837875, the US trial registry maintained by the National Library of Medicine. NCT01837875 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.